← Every applicant
Glenmark Pharms Ltd FDA Approvals
26 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| NINTEDANIB ESYLATENew drugJul 9, 2026CAPSULE, ORAL |
| SUCRALFATENew drugJan 5, 2026SUSPENSION, ORAL |
| TOPIRAMATENew drugJul 16, 2024CAPSULE, ORAL |
| BRIMONIDINE TARTRATE AND TIMOLOL MALEATENew drugMay 16, 2024SOLUTION/DROPS, OPHTHALMIC |
| ACETAMINOPHEN AND IBUPROFENNew drugApr 26, 2024TABLET, ORAL |
| FLUPHENAZINE HYDROCHLORIDENew drugNov 6, 2023TABLET, ORAL |
| APREMILASTNew drugOct 16, 2023TABLET, ORAL |
| SAXAGLIPTINNew drugJul 31, 2023TABLET, ORAL |
| CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATENew drugMar 21, 2023AEROSOL, FOAM, TOPICAL |
| PROCHLORPERAZINE MALEATENew drugMar 17, 2023TABLET, ORAL |
| CLINDAMYCIN HYDROCHLORIDENew drugMar 10, 2023CAPSULE, ORAL |
| NICARDIPINE HYDROCHLORIDENew drugDec 16, 2022CAPSULE, ORAL |
| SODIUM PHENYLBUTYRATENew drugNov 1, 2022TABLET, ORAL |
| NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATENew drugJul 27, 2022CAPSULE, ORAL |
| LACOSAMIDENew drugMar 17, 2022TABLET, ORAL |
| METRONIDAZOLENew drugJan 27, 2022GEL, VAGINAL |
| BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDENew drugJan 26, 2022TABLET, ORAL |
| CLINDAMYCIN PHOSPHATENew drugSep 20, 2021AEROSOL, FOAM, TOPICAL |
| ARFORMOTEROL TARTRATENew drugJun 22, 2021SOLUTION, INHALATION |
| THEOPHYLLINENew drugJun 3, 2021TABLET, EXTENDED RELEASE, ORAL |
| ICATIBANT ACETATENew drugMay 21, 2021INJECTABLE, SUBCUTANEOUS |
| CHLORPROMAZINE HYDROCHLORIDENew drugMar 23, 2021TABLET, ORAL |
| DILTIAZEM HYDROCHLORIDENew drugMar 22, 2021CAPSULE, EXTENDED RELEASE, ORAL |
| CLINDAMYCIN PHOSPHATENew drugFeb 10, 2021GEL, TOPICAL |
| TOPIRAMATENew drugFeb 1, 2021CAPSULE, EXTENDED RELEASE, ORAL |
| AMPHETAMINE SULFATENew drugJan 27, 2021TABLET, ORAL |